When you are trying to determine the appropriate surgery for patients with breast cancer, there should not be a trade-off between turnaround time and receiving an accurate, comprehensive hereditary cancer risk assessment. myRisk STAT® was developed for surgeons who need results they can trust, without the wait. When you order myRisk STAT for your patients with breast cancer, you will receive the report for the 11 breast cancer genes within 5-12 calendar days. In addition, you will receive the full Myriad myRisk® Hereditary Cancer Panel report in 14 days or less.
11 breast cancer genes reported in 5-12 calendar days. Full Myriad myRisk report in 14 calendar days or less.
Myriad myRisk is a 35-gene panel that identifies an elevated risk for eight important cancers.
*Patients with government payers (Medicare, Medicare Advantage, TriCare) are not eligible for myRisk STAT.